Enlace Health Taps Veteran CEO to Tackle Specialty Care Costs

ATLANTA, GA – April 16, 2026 – Enlace Health, a company focused on managing complex specialty healthcare, has appointed Dr. Craig Samitt, a prominent physician executive and former CEO of Blue Cross and Blue Shield of Minnesota, to its Board of Directors. The move signals a strategic escalation in the company's mission to bring financial and operational discipline to the most expensive and fragmented sectors of the U.S. healthcare system.

Dr. Samitt brings a formidable track record from leadership positions across both the payer and provider landscapes, including executive roles at Anthem and as CEO of Dean Health System. His appointment is seen as a significant validation of Enlace Health's technology-driven approach to value-based care.

“We are delighted to welcome Dr. Samitt to our Board,” said Bill Nordmark, President and CEO of Enlace Health, in a statement. “His experience leading organizations to deliver measurable financial and clinical outcomes, along with his understanding of specialty care performance, will be invaluable as we continue to scale our impact.”

The Soaring Cost of a Complex Problem

The timing of the appointment underscores a critical challenge facing the industry. While value-based care models have gained traction in primary care, specialty care—encompassing fields like cardiology, oncology, and orthopedics—remains a bastion of traditional fee-for-service payment models. This has allowed costs and complexity to spiral.

Recent industry analyses paint a stark picture. Direct spending on just six key specialty areas accounted for 38% of total medical spending in 2023, yet the total cost of care for patients utilizing those services represented a staggering 68% of all commercial and Medicare expenditures. Furthermore, spending in these areas grew by 9.3% between 2020 and 2023, far outpacing the 6.8% growth in all other medical sectors.

This financial pressure is creating unsustainable medical loss ratios for health plans and driving the need for new solutions. The problem is compounded by operational fragmentation, where patients often navigate a confusing web of specialists, hospitals, and primary care physicians with little coordination. It is this high-cost, high-complexity environment that Enlace Health aims to transform.

An 'Operating System' for Fragmented Care

Enlace Health positions its platform not as another single-point solution but as a comprehensive “operating system” for specialty care. The company’s Enlace Orchestrate platform is designed to unify analytics, financial processes, and care coordination workflows that are typically siloed within health plans and provider systems. By integrating data from claims, pharmacy, and clinical sources, the system aims to provide a single source of truth for managing value-based specialty programs.

This integrated model helps organizations design and scale programs that reward providers for quality and efficiency rather than volume. It provides tools for network management, provider engagement, and the automated administration of complex value-based contracts. The goal is to move healthcare organizations from a collection of fragmented initiatives to a scalable, repeatable model for delivering higher-quality, lower-cost specialty care.

Dr. Samitt highlighted this unique approach in his decision to join the board. “Specialty care is where much of the cost and complexity in healthcare resides, yet it remains one of the least consistently managed areas,” he stated. “Enlace is bringing a level of discipline, transparency, and operating rigor that has largely been missing. That combination of better insight, tighter execution, and aligned incentives is exactly what’s needed to improve performance in these high-impact areas.”

A Strategic Move Bolstered by Veteran Leadership

Dr. Samitt's career has been defined by his efforts to bridge the gap between payers and providers to advance value-based care. During his tenure as CEO of Blue Cross and Blue Shield of Minnesota, he championed groundbreaking partnerships with health systems aimed at moving away from volume-based reimbursement. At Anthem, he served as Chief Clinical Officer and President of its Diversified Business Group, where he was responsible for strategies to manage total cost of care and improve patient outcomes for millions of members.

His experience extends deep into the provider side as well, with leadership roles at integrated delivery networks like Dean Health System and HealthCare Partners. This dual perspective gives him a rare understanding of the incentives and operational hurdles that both sides face when trying to implement new payment models. His appointment lends significant weight to Enlace Health's claim that it can serve as a trusted infrastructure partner for both health plans and provider organizations.

Navigating a Competitive and Evolving Landscape

The push into value-based specialty care is becoming an increasingly active and competitive field. As payers and the federal government intensify their focus on controlling costs, a new ecosystem of “value-based care enablers” has emerged. While some companies focus on primary care, a growing number are targeting specific high-cost specialties like nephrology, oncology, and cardiology.

Enlace Health differentiates itself by offering a specialty-agnostic platform designed to manage multiple conditions and programs simultaneously. The company’s ability to support new federal initiatives, such as the Centers for Medicare and Medicaid Innovation’s (CMMI) Transforming Episode Accountability Model (TEAM), further positions it as a key player in the national transition away from fee-for-service.

In this dynamic market, strong leadership and deep industry knowledge are critical differentiators. By bringing Dr. Samitt into its inner circle, Enlace Health is not only gaining a seasoned guide with an unparalleled network and understanding of healthcare’s inner workings but is also sending a clear message to the market. The company is poised to lead the charge in systematically addressing the cost and quality of specialty care, an effort that could have profound implications for the sustainability of the American healthcare system.